BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol 2019;234:17187-204. [DOI: 10.1002/jcp.28504] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Elbanna M, Chowdhury NN, Rhome R, Fishel ML. Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy. Front Oncol 2021;11:749496. [PMID: 34733787 DOI: 10.3389/fonc.2021.749496] [Reference Citation Analysis]
2 Mrakovcic M, Fröhlich LF. Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy. Cancers (Basel) 2019;12:E109. [PMID: 31906235 DOI: 10.3390/cancers12010109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Keyvani-Ghamsari S, Khorsandi K, Gul A. Curcumin effect on cancer cells' multidrug resistance: An update. Phytother Res 2020;34:2534-56. [PMID: 32307747 DOI: 10.1002/ptr.6703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Du XZ, Wen B, Liu L, Wei YT, Zhao K. Role of immune escape in different digestive tumours. World J Clin Cases 2021; 9(34): 10438-10450 [PMID: 35004976 DOI: 10.12998/wjcc.v9.i34.10438] [Reference Citation Analysis]
5 Harrington BS, Annunziata CM. NF-κB Signaling in Ovarian Cancer. Cancers (Basel) 2019;11:E1182. [PMID: 31443240 DOI: 10.3390/cancers11081182] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
6 Mu Q, Najafi M. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells. Int Immunopharmacol 2021;98:107895. [PMID: 34171623 DOI: 10.1016/j.intimp.2021.107895] [Reference Citation Analysis]
7 Mortezaee K. Organ tropism in solid tumor metastasis: an updated review. Future Oncology 2021;17:1943-61. [DOI: 10.2217/fon-2020-1103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Fu X, Li M, Tang C, Huang Z, Najafi M. Targeting of cancer cell death mechanisms by resveratrol: a review. Apoptosis 2021;26:561-73. [PMID: 34561763 DOI: 10.1007/s10495-021-01689-7] [Reference Citation Analysis]
9 Mortezaee K. Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives. Life Sci 2021;277:119627. [PMID: 34004256 DOI: 10.1016/j.lfs.2021.119627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hu Y, Xu R, Ma J, Yan Z, Ma J. Curcumol enhances cisplatin sensitivity of gastric cancer: involvement of microRNA-7 and the nuclear factor-kappa B/snail family transcriptional repressor 1 axis. Bioengineered 2022;13:11668-83. [PMID: 35510522 DOI: 10.1080/21655979.2022.2070975] [Reference Citation Analysis]
11 Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. Damage-associated molecular patterns in tumor radiotherapy. Int Immunopharmacol 2020;86:106761. [PMID: 32629409 DOI: 10.1016/j.intimp.2020.106761] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
12 Mortezaee K, Parwaie W, Motevaseli E, Mirtavoos-mahyari H, Musa AE, Shabeeb D, Esmaely F, Najafi M, Farhood B. Targets for improving tumor response to radiotherapy. International Immunopharmacology 2019;76:105847. [DOI: 10.1016/j.intimp.2019.105847] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
13 Oh K, Song J, Min KH. Discovery of Novel Imidazothiazole Derivatives as NF‐κB Inhibitors. Bull Korean Chem Soc 2019;40:1148-9. [DOI: 10.1002/bkcs.11892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Pu L, Chen WH, Cao LX, Wu KJ, Chen SL, Lin JH, Li CL, Wang SQ, Zhu MM, Zhang YM. Compound Kushen Injection as an Adjunctive Therapy for the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2019;2019:7241927. [PMID: 31781277 DOI: 10.1155/2019/7241927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Majidpoor J, Mortezaee K. Interleukin-2 therapy of cancer-clinical perspectives. Int Immunopharmacol 2021;98:107836. [PMID: 34218217 DOI: 10.1016/j.intimp.2021.107836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang R, Tan C, Najafi M. Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents. Inflammopharmacology 2021. [PMID: 34813027 DOI: 10.1007/s10787-021-00894-9] [Reference Citation Analysis]
17 Cai BQ, Chen WM, Zhao J, Hou W, Tang JC. Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In Vivo. J Oncol 2021;2021:9355555. [PMID: 34795760 DOI: 10.1155/2021/9355555] [Reference Citation Analysis]
18 Majidpoor J, Mortezaee K. Steps in metastasis: an updated review. Med Oncol 2021;38:3. [PMID: 33394200 DOI: 10.1007/s12032-020-01447-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
19 Song XD, Wang YN, Zhang AL, Liu B. Advances in research on the interaction between inflammation and cancer. J Int Med Res 2020;48:300060519895347. [PMID: 31885347 DOI: 10.1177/0300060519895347] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Palma-Lara I, Martínez-Castillo M, Quintana-Pérez JC, Arellano-Mendoza MG, Tamay-Cach F, Valenzuela-Limón OL, García-Montalvo EA, Hernández-Zavala A. Arsenic exposure: A public health problem leading to several cancers. Regul Toxicol Pharmacol 2020;110:104539. [PMID: 31765675 DOI: 10.1016/j.yrtph.2019.104539] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
21 Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol 2021;907:174365. [PMID: 34302814 DOI: 10.1016/j.ejphar.2021.174365] [Reference Citation Analysis]
22 Khodamoradi E, Hoseini-Ghahfarokhi M, Amini P, Motevaseli E, Shabeeb D, Musa AE, Najafi M, Farhood B. Targets for protection and mitigation of radiation injury. Cell Mol Life Sci 2020;77:3129-59. [PMID: 32072238 DOI: 10.1007/s00018-020-03479-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
23 Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Front Chem 2020;8:829. [PMID: 33195038 DOI: 10.3389/fchem.2020.00829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
24 Zhang GZ, Liu MQ, Chen HW, Wu ZL, Gao YC, Ma ZJ, He XG, Kang XW. NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif 2021;54:e13057. [PMID: 34028920 DOI: 10.1111/cpr.13057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Huang J, Chang Z, Lu Q, Chen X, Najafi M. Nobiletin as an inducer of programmed cell death in cancer: a review. Apoptosis 2022. [PMID: 35312885 DOI: 10.1007/s10495-022-01721-4] [Reference Citation Analysis]
26 Song A, Wang Y, Jiang F, Yan E, Zhou J, Ye J, Zhang H, Ding X, Li G, Wu Y, Zheng Y, Song X. Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling. Mol Cells 2021;44:468-80. [PMID: 34230226 DOI: 10.14348/molcells.2021.2229] [Reference Citation Analysis]
27 Samadi M, Haghi-Aminjan H, Sattari M, Hooshangi Shayesteh MR, Bameri B, Armandeh M, Naddafi M, Eghbal MA, Abdollahi M. The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study. Life Sci 2021;265:118813. [PMID: 33275984 DOI: 10.1016/j.lfs.2020.118813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance. Int J Mol Sci 2020;21:E4002. [PMID: 32503307 DOI: 10.3390/ijms21114002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 19.0] [Reference Citation Analysis]
29 Mercantepe T, Topcu A, Rakici S, Tumkaya L, Yilmaz A, Mercantepe F. The radioprotective effect of N-acetylcysteine against x-radiation-induced renal injury in rats. Environ Sci Pollut Res Int 2019;26:29085-94. [PMID: 31392607 DOI: 10.1007/s11356-019-06110-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Fu X, Tang J, Wen P, Huang Z, Najafi M. Redox interactions-induced cardiac toxicity in cancer therapy. Arch Biochem Biophys 2021;708:108952. [PMID: 34097901 DOI: 10.1016/j.abb.2021.108952] [Reference Citation Analysis]
31 Wei J, Wang B, Wang H, Meng L, Zhao Q, Li X, Xin Y, Jiang X. Radiation-Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms. Oxid Med Cell Longev 2019;2019:3010342. [PMID: 31781332 DOI: 10.1155/2019/3010342] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
32 Rad AT, Hargrove D, Daneshmandi L, Ramsdell A, Lu X, Nieh M. Codelivery of Paclitaxel and Parthenolide in Discoidal Bicelles for a Synergistic Anticancer Effect: Structure Matters. Advanced NanoBiomed Research 2022;2:2100080. [DOI: 10.1002/anbr.202100080] [Reference Citation Analysis]
33 Stati G, Passaretta F, Gindraux F, Centurione L, Di Pietro R. The Role of the CREB Protein Family Members and the Related Transcription Factors in Radioresistance Mechanisms. Life (Basel) 2021;11:1437. [PMID: 34947968 DOI: 10.3390/life11121437] [Reference Citation Analysis]
34 Ding DN, Xie LZ, Shen Y, Li J, Guo Y, Fu Y, Liu FY, Han FJ. Insights into the Role of Oxidative Stress in Ovarian Cancer. Oxid Med Cell Longev 2021;2021:8388258. [PMID: 34659640 DOI: 10.1155/2021/8388258] [Reference Citation Analysis]
35 Mortezaee K. Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer. J Biochem Mol Toxicol 2021;35:e22708. [PMID: 33491255 DOI: 10.1002/jbt.22708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
36 Molendijk EBD, Blijlevens NMA. NO, way to go: critical amino acids to replenish nitric oxide production in treating mucositis. Curr Opin Support Palliat Care 2021;15:188-96. [PMID: 34397582 DOI: 10.1097/SPC.0000000000000560] [Reference Citation Analysis]
37 Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, Najafi M. TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res 2020;155:104745. [PMID: 32145401 DOI: 10.1016/j.phrs.2020.104745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
38 Mortezaee K, Majidpoor J. (Im)maturity in Tumor Ecosystem. Front Oncol 2022;11:813897. [DOI: 10.3389/fonc.2021.813897] [Reference Citation Analysis]
39 Majidpoor J, Mortezaee K. Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications. Biomed Pharmacother 2021;145:112419. [PMID: 34781146 DOI: 10.1016/j.biopha.2021.112419] [Reference Citation Analysis]
40 Mortezaee K. Redox tolerance and metabolic reprogramming in solid tumors. Cell Biol Int 2021;45:273-86. [PMID: 33236822 DOI: 10.1002/cbin.11506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Agbele AT, Fasoro OJ, Fabamise OM, Oluyide OO, Idolor OR, Bamise EA. Protection Against Ionizing Radiation-Induced Normal Tissue Damage by Resveratrol: A Systematic Review. Eurasian J Med 2020;52:298-303. [PMID: 33209085 DOI: 10.5152/eurasianjmed.2020.20143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Sonis ST. A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment. Support Care Cancer 2021;29:4939-47. [PMID: 33712912 DOI: 10.1007/s00520-021-06108-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Yu C, Yang B, Najafi M. Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy. Basic Clin Pharmacol Toxicol 2021. [PMID: 34473898 DOI: 10.1111/bcpt.13648] [Reference Citation Analysis]
44 Abe H, Okazawa M, Oyama T, Yamazaki H, Yoshimori A, Kamiya T, Tsukimoto M, Takao K, Sugita Y, Sakagami H, Abe T, Tanuma SI. A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines (Basel) 2021;8:17. [PMID: 33805209 DOI: 10.3390/medicines8040017] [Reference Citation Analysis]
45 Chen L, Musa AE. Boosting immune system against cancer by resveratrol. Phytother Res 2021. [PMID: 34101276 DOI: 10.1002/ptr.7189] [Reference Citation Analysis]
46 Mortezaee K. Normalization in tumor ecosystem: Opportunities and challenges. Cell Biol Int 2021. [PMID: 34189798 DOI: 10.1002/cbin.11655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Jahanafrooz Z, Mosafer J, Akbari M, Hashemzaei M, Mokhtarzadeh A, Baradaran B. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. J Cell Physiol 2020;235:4153-66. [PMID: 31647128 DOI: 10.1002/jcp.29337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]